These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1895293)

  • 1. Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor.
    Orlek BS; Blaney FE; Brown F; Clark MS; Hadley MS; Hatcher J; Riley GJ; Rosenberg HE; Wadsworth HJ; Wyman P
    J Med Chem; 1991 Sep; 34(9):2726-35. PubMed ID: 1895293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and In vitro binding affinities of 1-azabicyclic compounds as muscarinic ligands.
    Cha JH; Cho YS; Pae AN; Koh HY; Jeong D; Kong JY; Lee E; Choi KI
    Bioorg Med Chem Lett; 2001 Nov; 11(21):2855-7. PubMed ID: 11597415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors.
    Street LJ; Baker R; Book T; Kneen CO; MacLeod AM; Merchant KJ; Showell GA; Saunders J; Herbert RH; Freedman SB
    J Med Chem; 1990 Oct; 33(10):2690-7. PubMed ID: 2213823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel quinuclidine-based ligands for the muscarinic cholinergic receptor.
    Saunders J; Cassidy M; Freedman SB; Harley EA; Iversen LL; Kneen C; MacLeod AM; Merchant KJ; Snow RJ; Baker R
    J Med Chem; 1990 Apr; 33(4):1128-38. PubMed ID: 2319559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonists.
    Triggle DJ; Kwon YW; Abraham P; Rahman MA; Carroll FI
    Pharm Res; 1992 Nov; 9(11):1474-9. PubMed ID: 1475236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and muscarinic receptor activity of ester derivatives of 2-substituted 2-azabicyclo[2.2.1]heptan-5-ol and -6-ol.
    Carroll FI; Abraham P; Chemburkar S; He XC; Mascarella SW; Kwon YW; Triggle DJ
    J Med Chem; 1992 Jun; 35(12):2184-91. PubMed ID: 1613746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel series of non-quaternary oxadiazoles acting as full agonists at muscarinic receptors.
    Freedman SB; Harley EA; Patel S; Newberry NR; Gilbert MJ; McKnight AT; Tang JK; Maguire JJ; Mudunkotuwa NT; Baker R
    Br J Pharmacol; 1990 Nov; 101(3):575-80. PubMed ID: 2076477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituent variation in azabicyclic triazole- and tetrazole-based muscarinic receptor ligands.
    Jenkins SM; Wadsworth HJ; Bromidge S; Orlek BS; Wyman PA; Riley GJ; Hawkins J
    J Med Chem; 1992 Jun; 35(13):2392-406. PubMed ID: 1619616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.
    Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB
    Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C(8)-substituted 1-azabicyclo[3.3.1]non-3-enes: a novel scaffold for muscarinic receptor ligands.
    Kim MG; Bodor ET; Harden TK; Kohn H
    Bioorg Med Chem; 2004 May; 12(9):2357-67. PubMed ID: 15080933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.
    Bromidge SM; Brown F; Cassidy F; Clark MS; Dabbs S; Hadley MS; Hawkins J; Loudon JM; Naylor CB; Orlek BS; Riley GJ
    J Med Chem; 1997 Dec; 40(26):4265-80. PubMed ID: 9435896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and muscarinic activity of quinuclidinyl- and (1-azanorbornyl)pyrazine derivatives.
    Street LJ; Baker R; Book T; Reeve AJ; Saunders J; Willson T; Marwood RS; Patel S; Freedman SB
    J Med Chem; 1992 Jan; 35(2):295-305. PubMed ID: 1732546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrahydropyridyloxadiazoles: semirigid muscarinic ligands.
    Showell GA; Gibbons TL; Kneen CO; MacLeod AM; Merchant K; Saunders J; Freedman SB; Patel S; Baker R
    J Med Chem; 1991 Mar; 34(3):1086-94. PubMed ID: 2002451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and muscarinic activity of a series of quinolines and naphthalenes with a 1-azabicyclo[3.3.0]octane moiety.
    Suzuki T; Usui T; Oka M; Suzuki T; Kataoka T
    Chem Pharm Bull (Tokyo); 1998 Aug; 46(8):1265-73. PubMed ID: 9734314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-[2-(1-azabicyclo[3.3.0]octan-5-yl)ethyl]-2-nitroaniline, a potent muscarinic agonist.
    Suzuki T; Oka M; Maeda K; Furusawa K; Mitani T; Kataoka T
    Chem Pharm Bull (Tokyo); 1997 Jul; 45(7):1218-20. PubMed ID: 9246754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-687,306: a functionally selective and potent muscarinic M1 receptor agonist.
    Freedman SB; Patel S; Harley EA; Iversen LL; Baker R; Showell GA; Saunders J; McKnight A; Newberry N; Scholey K
    Eur J Pharmacol; 1992 Apr; 215(1):135-6. PubMed ID: 1516645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and muscarinic activity of novel aniline derivatives with a 1-azabicyclo[3.3.0]octane moiety.
    Suzuki T; Oka M; Maeda K; Furusawa K; Uesaka H; Kataoka T
    Chem Pharm Bull (Tokyo); 1999 Jan; 47(1):28-36. PubMed ID: 9987823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of functional interactions of imidazoquinoxaline derivatives with benzodiazepine-gamma-aminobutyric acidA receptors.
    Petke JD; Im HK; Im WB; Blakeman DP; Pregenzer JF; Jacobsen EJ; Hamilton BJ; Carter DB
    Mol Pharmacol; 1992 Aug; 42(2):294-301. PubMed ID: 1355261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and SAR of bulky 1-azabicyclo[2.2.1]-3-one oximes as muscarinic receptor subtype selective agonists.
    Tecle H; Lauffer DJ; Mirzadegan T; Moos WH; Moreland DW; Pavia MR; Schwarz RD; Davis RE
    Life Sci; 1993; 52(5-6):505-11. PubMed ID: 8382765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivatives.
    Wadsworth HJ; Jenkins SM; Orlek BS; Cassidy F; Clark MS; Brown F; Riley GJ; Graves D; Hawkins J; Naylor CB
    J Med Chem; 1992 Apr; 35(7):1280-90. PubMed ID: 1560440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.